Vitalis is a pre-clinical stage pharmaceutical company that is dedicated to changing the treatment of multiple sclerosis, post-op pain (non-opioid), and dyslipidemia through innovative therapies. Vitalis hopes to address major side effects of some of these treatments, such as flush, while also improving outcomes.